These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function. Stampfer M; Epstein SE; Beiser GD; Braunwald E Circulation; 1968 Jun; 37(6):900-11. PubMed ID: 5653053 [No Abstract] [Full Text] [Related]
7. Congestive and hypertrophic cardiomyopathies. A decade of study. Goodwin JF Lancet; 1970 Apr; 1(7650):732-9. PubMed ID: 4191245 [No Abstract] [Full Text] [Related]
8. Co-existing aortic stenosis and secondary hypertrophic cardiomyopathy manifested by an hourglass left ventricle. Successful treatment with verapamil. Hasin Y; Rod JL; Friedman G Chest; 1979 Aug; 76(2):232-4. PubMed ID: 156629 [TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blocking agents in hypertrophic cardiomyopathy (HOCM). Oakley CM Singapore Med J; 1973 Sep; 14(3):408-9. PubMed ID: 4149721 [No Abstract] [Full Text] [Related]
11. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy. Yang T; Brittenham GM; Dong WQ; Levy MN; Obejero-Paz CA; Kuryshev YA; Brown AM J Lab Clin Med; 2003 Nov; 142(5):332-40. PubMed ID: 14647037 [TBL] [Abstract][Full Text] [Related]
12. Influence of drug therapy on myocardial hypertrophy in left ventricular failure. Taylor SH J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S141-7. PubMed ID: 2485020 [TBL] [Abstract][Full Text] [Related]
13. Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Bennett SK; Smith MF; Gottlieb SS; Fisher ML; Bacharach SL; Dilsizian V Am J Cardiol; 2002 Jun; 89(12):1431-4. PubMed ID: 12062744 [No Abstract] [Full Text] [Related]